Ligand Pharmaceuticals Incorporated Stock Price on January 7, 2025
| LGND Stock | USD 115.86 1.50 1.28% |
Below is the normalized historical share price chart for Ligand Pharmaceuticals Incorporated extending back to November 18, 1992. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Ligand Pharmaceuticals stands at 115.86, as last reported on the 23rd of January, with the highest price reaching 119.00 and the lowest price hitting 113.99 during the day.
If you're considering investing in Ligand Stock, it is important to understand the factors that can impact its price. At this point, Ligand Pharmaceuticals is very steady. Ligand Pharmaceuticals has Sharpe Ratio of 0.0345, which conveys that the firm had a 0.0345 % return per unit of risk over the last 3 months. We have found thirty technical indicators for Ligand Pharmaceuticals, which you can use to evaluate the volatility of the firm. Please verify Ligand Pharmaceuticals' Risk Adjusted Performance of 0.0524, mean deviation of 2.21, and Downside Deviation of 3.44 to check out if the risk estimate we provide is consistent with the expected return of 0.11%.
At present, Ligand Pharmaceuticals' Liabilities And Stockholders Equity is projected to increase significantly based on the last few years of reporting. . At present, Ligand Pharmaceuticals' Price Earnings Ratio is projected to increase significantly based on the last few years of reporting. The current year's Price Sales Ratio is expected to grow to 9.20, whereas Price Earnings To Growth Ratio is projected to grow to (0.02). Ligand Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 18th of November 1992 | 200 Day MA 99.1301 | 50 Day MA 115.7252 | Beta 0.896 |
Ligand |
Sharpe Ratio = 0.0345
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | LGND | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.21 actual daily | 28 72% of assets are more volatile |
Expected Return
| 0.11 actual daily | 2 98% of assets have higher returns |
Risk-Adjusted Return
| 0.03 actual daily | 2 98% of assets perform better |
Based on monthly moving average Ligand Pharmaceuticals is performing at about 2% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Ligand Pharmaceuticals by adding it to a well-diversified portfolio.
Price Book 2.6026 | Enterprise Value Ebitda 20.6468 | Price Sales 14.3629 | Shares Float 18.5 M | Wall Street Target Price 144 |
Related Headline
Oric Pharmaceuticals Headline on 7th of January 2025
ORIC Pharmaceuticals Sees Unusually-High Trading Volume - Wh... by news.google.com
ORIC Pharmaceuticals Sees Unusually-High Trading Volume - Whats Next MarketBeat
Ligand Pharmaceuticals Valuation on January 7, 2025
It is possible to determine the worth of Ligand Pharmaceuticals on a given historical date. On January 7, 2025 Ligand was worth 107.7 at the beginning of the trading date compared to the closed value of 110.31. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Ligand Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find Ligand Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Ligand Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Ligand Pharmaceuticals' related companies.
| Open | High | Low | Close | Volume | |
| 110.32 | 112.61 | 107.57 | 107.92 | 72,082 | |
01/07/2025 | 107.70 | 111.65 | 107.70 | 110.31 | 94,566 |
| 110.43 | 110.91 | 107.94 | 110.58 | 66,979 |
| Backtest Ligand Pharmaceuticals | | | Ligand Pharmaceuticals History | | | Ligand Pharmaceuticals Valuation | Previous | Next |
Ligand Pharmaceuticals Trading Date Momentum on January 7, 2025
| On January 08 2025 Ligand Pharmaceuticals Incorporated was traded for 110.58 at the closing time. The top price for the day was 110.91 and the lowest listed price was 107.94 . The trading volume for the day was 67 K. The trading history from January 8, 2025 was a factor to the next trading day price growth. The trading delta at closing time against the next closing price was 0.24% . The trading delta at closing time against the current closing price is 0.70% . |
Ligand Pharmaceuticals Fundamentals Correlations and Trends
By evaluating Ligand Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Ligand Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Ligand financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Ligand Pharmaceuticals Stock history
Ligand Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Ligand is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Ligand Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Ligand Pharmaceuticals stock prices may prove useful in developing a viable investing in Ligand Pharmaceuticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 20.4 M | 16.2 M | |
| Net Loss | -38.4 M | -36.4 M |
Ligand Pharmaceuticals Quarterly Net Working Capital |
|
Ligand Pharmaceuticals Stock Technical Analysis
Ligand Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Ligand Pharmaceuticals Period Price Range
Low | January 23, 2025
| High |
0.00 | 0.00 |
Ligand Pharmaceuticals Incorporated cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Ligand Pharmaceuticals January 23, 2025 Market Strength
Market strength indicators help investors to evaluate how Ligand Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Ligand Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Ligand Pharmaceuticals stock market strength indicators, traders can identify Ligand Pharmaceuticals Incorporated entry and exit signals to maximize returns
Ligand Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Ligand Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Ligand Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Ligand to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0524 | |||
| Jensen Alpha | 0.1388 | |||
| Total Risk Alpha | 0.0625 | |||
| Sortino Ratio | 0.0376 | |||
| Treynor Ratio | 0.2443 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Ligand Stock analysis
When running Ligand Pharmaceuticals' price analysis, check to measure Ligand Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ligand Pharmaceuticals is operating at the current time. Most of Ligand Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Ligand Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ligand Pharmaceuticals' price. Additionally, you may evaluate how the addition of Ligand Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |